Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-08-30 21:40:37 UTC
Update Date2021-09-26 22:48:57 UTC
HMDB IDHMDB0242425
Secondary Accession NumbersNone
Metabolite Identification
Common Name(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol
DescriptionAC1L9XJ3 belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. AC1L9XJ3 is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). (1s,17r)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC19H24N2O
Average Molecular Weight296.414
Monoisotopic Molecular Weight296.188863401
IUPAC Name17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-ol
Traditional Name17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-ol
CAS Registry NumberNot Available
SMILES
CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=C(O)C=C12
InChI Identifier
InChI=1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3
InChI KeyRAUCDOKTMDOIPF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond.
KingdomOrganic compounds
Super ClassAlkaloids and derivatives
ClassIbogan-type alkaloids
Sub ClassNot Available
Direct ParentIbogan-type alkaloids
Alternative Parents
Substituents
  • Ibogan skeleton
  • Catharanthine skeleton
  • Hydroxyindole
  • Pyrroloazepine
  • 3-alkylindole
  • Indole
  • Indole or derivatives
  • Azepine
  • 1-hydroxy-2-unsubstituted benzenoid
  • Aralkylamine
  • Piperidine
  • Benzenoid
  • Heteroaromatic compound
  • Pyrrole
  • Tertiary amine
  • Tertiary aliphatic amine
  • Organoheterocyclic compound
  • Azacycle
  • Organooxygen compound
  • Organonitrogen compound
  • Amine
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.04ALOGPS
logP3ChemAxon
logS-3.6ALOGPS
pKa (Strongest Acidic)9.66ChemAxon
pKa (Strongest Basic)8.87ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area39.26 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity89.09 m³·mol⁻¹ChemAxon
Polarizability34.8 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-205.77830932474
DeepCCS[M+Na]+181.34330932474
AllCCS[M+H]+173.532859911
AllCCS[M+H-H2O]+170.432859911
AllCCS[M+NH4]+176.432859911
AllCCS[M+Na]+177.332859911
AllCCS[M-H]-176.632859911
AllCCS[M+Na-2H]-176.232859911
AllCCS[M+HCOO]-175.832859911

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]42882.1Semi standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]42917.4Standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]43599.7Standard polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C2925.6Semi standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C2846.3Standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C3532.4Standard polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C2886.8Semi standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C2815.4Standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C3347.2Standard polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]43110.7Semi standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]43185.4Standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]43715.2Standard polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C3101.3Semi standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C3117.8Standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C3621.6Standard polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C3261.7Semi standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C3318.5Standard non polar33892256
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C3487.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positivesplash10-014i-1290000000-f4b5acd785b6c643f7682021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 10V, Positive-QTOFsplash10-0002-0090000000-7a52ccd6b135811522742021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 20V, Positive-QTOFsplash10-0002-0090000000-7a52ccd6b135811522742021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 40V, Positive-QTOFsplash10-0400-0980000000-7591e714ad6a83186bf42021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 10V, Negative-QTOFsplash10-0002-0090000000-6097eef1edfc41faed9b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 20V, Negative-QTOFsplash10-0002-0090000000-6097eef1edfc41faed9b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 40V, Negative-QTOFsplash10-00kf-0190000000-4198e3f8928f0e0784e62021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound457967
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]